Two New Publications from the Independent THERMAC Trial Featuring IceCure's ProSense® in Breast Cancer Finds 95% of Patients Satisfied with Thermal Ablation; ProSense® Cryoablation Achieves Highest Complete Ablation Rate
Provided By PR Newswire
Last update: Sep 8, 2025
Article published in European Journal of Surgical Oncology focused on cosmetic outcomes and patient satisfaction reports 95% of patients were very satisfied or satisfied with thermal ablation
Read more at prnewswire.comNASDAQ:ICCM (9/25/2025, 3:00:21 PM)
1.03
-0.02 (-1.9%)
Find more stocks in the Stock Screener
